The oral Covid-19 drug molnupiravir eliminates the SARS-CoV-2 virus in its active infectious phase by the third day from the start of taking it, reveals a study to be presented at the European Congress of Clinical Microbiology and Infectious Diseases next week. "Many patients" who received a placebo took up to five days to clear it...
